Gossamer Bio (GOSS) Price to FCF (2019 - 2026)
Gossamer Bio (GOSS) posted Price to FCF of 1.3 for Q2 2026, up 35.07% on a QoQ basis from 2.0 in Q1 2026, and up 78.12% year-over-year from 0.73 in Q2 2025.
Analysis
Gossamer Bio (GOSS) Price to FCF (2019 - 2026) Analysis & Trends
Gossamer Bio has reported Price to FCF for 8 years, with the latest figure at 1.3 in Q2 2026.
- On a quarterly basis, Price to FCF rose 78.12% year-over-year to 1.3 in Q2 2026; TTM through Jun 2026 was 0.31, a 82.62% increase from a year earlier, with the FY2025 full-year figure at 4.23, up 92.81% from the prior year.
- Price to FCF was 1.3 for Q2 2026 at Gossamer Bio, up from 2.0 in the prior quarter.
- The five-year high for Price to FCF was 1.75 in Q2 2024, with the low at 30.38 in Q3 2022.
- Average Price to FCF over 5 years is 7.69, with a median of 5.59 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Price to FCF soared 158.44% in 2024, then plunged 439.13% in 2025.
- Over 5 years, Price to FCF stood at 4.28 in 2022, then climbed by 3.0% to 4.16 in 2023, then tumbled by 38.33% to 5.75 in 2024, then plunged by 160.85% to 14.99 in 2025, then jumped by 91.34% to 1.3 in 2026.
- The last three Price to FCF figures came in at 1.3 (Q2 2026), 2.0 (Q1 2026), and 14.99 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Gossamer Bio | 51.23 Mn | -5.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.30 |
| Mar 31, 2026 | -2.00 |
| Dec 31, 2025 | -14.99 |
| Sep 30, 2025 | -16.82 |
| Jun 30, 2025 | -5.93 |
| Mar 31, 2025 | -6.29 |
| Dec 31, 2024 | -5.75 |
| Sep 30, 2024 | -7.00 |
| Jun 30, 2024 | 1.75 |
| Mar 31, 2024 | -5.10 |
| Dec 31, 2023 | -4.16 |
| Sep 30, 2023 | -5.42 |
| Jun 30, 2023 | -2.99 |
| Mar 31, 2023 | -2.27 |
| Dec 31, 2022 | -4.28 |
| Sep 30, 2022 | -30.38 |
| Jun 30, 2022 | -13.12 |
| Mar 31, 2022 | -12.39 |
| Dec 31, 2021 | -21.11 |
| Sep 30, 2021 | -22.24 |